Pediatric Phase 1/Pilot Consortium (Limited Competition UM1)

Post Date

January 5th 2012

Application Due Date

March 20th 2012

Funding Opportunity Number

RFA-CA-12-502

CFDA Number(s)

93.395

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Education
Health

Number of Awards

1

Eligibility Categories

Other

Other Eligible Applicants include the following: The eligibility to apply in response to this FOA is limited to the current recipient of the Children's Oncology Group Phase 1/Pilot Consortium award.

Funding

• Estimated Total Funding:

  $3470000

• Award Range:

  $None - $None

Grant Description

The purpose of this Funding opportunity Announcement (FOA) is to continue the NCIs program for Pediatric Phase 1/Pilot Consortium. The function of the Consortium is to conduct Phase 1 and pilot studies in children with cancer so that new agents can be introduced into the pediatric oncology setting in a timely manner. The Consortium's ability to quickly conduct first in children studies is critical to NCIs overall clinical research program for children with cancer. To accomplish the objectives of the FOA, a strong multi-institutional, multi-disciplinary research team is needed that can rapidly and efficiently design and conduct Phase 1 and pilot clinical trials and that is experienced in doing so within the ethical constraints applicable to research involving children. The ultimate purpose for supporting the Pediatric Phase 1/Pilot Consortium is to improve therapy outcomes for children with cancer.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-502.html